A compound with the SMILES Cc1c(NC(=O)CSc2nc(C(C)(C)C)cs2)c(=O)n(-c2ccccc2)n1C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 11.376\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1c(NC(=O)CSc2nc(C(C)(C)C)cs2)c(=O)n(-c2ccccc2)n1C
Cc1c(NC(=O)CSc2nc(C(C)(C)C)cs2)c(=O)n(-c2ccccc2)n1C
[C][C][=C][Branch2][Ring1][=Branch2][N][C][=Branch1][C][=O][C][S][C][=N][C][Branch1][=Branch2][C][Branch1][C][C][Branch1][C][C][C][=C][S][Ring1][=Branch2][C][=Branch1][C][=O][N][Branch1][=Branch2][C][=C][C][=C][C][=C][Ring1][=Branch1][N][Ring2][Ring1][#Branch2][C]
2-[(4-tert-butyl-1,3-thiazol-2-yl)sulfanyl]-N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)acetamide